• About CCSB
  • |
  • News
  • |
  • Contact Us
  • |
  • Site Map
  •  
  •   中文版
CCSB's
  • ESG
  • Investor Relations
  • Events
  • Contract Research
  • Contract Manufacturing
  • API Products
CCSB API Products

API Products

Announcements
Financial
Annual Reports
Shareholders Services

Announcements

Home > Investor Relations >Announcements
2022/11/08 On behalf of major subsidiary PHARMAPORTS,LLC to announce the change of Chairman
2022/11/08 On behalf of major subsidiary PHARMAPORTS,LLC to announce the change of representative of legal person director
2022/09/19 Clarification for news on page B4 of Economic Daily News dated September 17, 2022
2022/08/22 CCSB is invited to attend the Investor Conference held by Yuanta Securities
2022/08/09 Announce the company's 2022Q2 consolidated financial reports approved by the board of directors
2022/08/09 The board of directors approved the appointment of the general manager
2022/08/01 Announcement of the change of the general manager
2022/06/28 The board of directors resolved the ex-dividend record date of dividend distribution
2022/06/28 Announcement of the change of Spokesperson, Acting spokesperson
2022/05/25 Announcement of election result of Directors (including independent directors)
 Prev 1  2  3  4  5  6  7  8  9  10 Next  
© Chunghwa Chemical Synthesis & Biotech Co. Ltd. All right reserved.